<DOC>
	<DOCNO>NCT02998112</DOCNO>
	<brief_summary>To indicate efficacy Fecal microbiota transplantation ( FMT ) treatment Ulcerative colitis ( UC ) , The investigator design multicenter , randomize control trial perform FMT colonic transendoscopic enteral tubing ( TET ) way , evaluate efficacy safety FMT patient moderate severe UC .</brief_summary>
	<brief_title>Fecal Microbiota Transplantation Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing</brief_title>
	<detailed_description>1 . Patients moderate severe UC screen ( Mayo &gt; 6ï¼‰ . 2 . Participants divide control study group double blind . 3 . Control group study group receive colonic endoscopy evaluation . And TET tube fix ileocecum . 4 . Enema 5-ASA 4g/day 7days TET perform basic therapy control study group . Study control group give fecal microbiota suspension equal volume saline TET three time every day one week . 5 . The follow-up perform 1 week , 4 week 12 week first treatment . All participant receive endoscopy evaluation 12 week . Clinical remission , clinical improvement safety primary endpoint 12 week ; Intestinal microbiota change recognize secondary endpoint .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Active , moderate severe severity ( Mayo score 6 ) Safety use history 5ASA . Able undergo endoscopy examination . Immunosuppressive drug glucocorticoid use 4 week Antibiotic use 7 day High risk toxic megacolon Colon cancer neoplasia pathophysiology Other severe disease ( eg : cardiovascular , respiratory , gastroenteral kidney disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>fecal microbiota transplantation</keyword>
	<keyword>Ulcerative colitis</keyword>
</DOC>